EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 190 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,997,644 | -71.8% | 2,646,366 | -39.1% | 0.00% | -100.0% |
| Q2 2023 | $31,916,214 | -43.3% | 4,342,342 | -20.1% | 0.00% | 0.0% |
| Q1 2023 | $56,281,995 | -11.9% | 5,432,625 | +0.5% | 0.00% | -50.0% |
| Q4 2022 | $63,848,096 | -41.4% | 5,406,274 | +4.1% | 0.00% | -33.3% |
| Q3 2022 | $108,969,000 | -31.0% | 5,191,486 | +2.0% | 0.00% | -25.0% |
| Q2 2022 | $158,007,000 | -25.4% | 5,090,427 | -1.3% | 0.00% | -20.0% |
| Q1 2022 | $211,721,000 | -9.2% | 5,156,381 | -3.8% | 0.01% | 0.0% |
| Q4 2021 | $233,088,000 | -5.4% | 5,362,031 | +8.9% | 0.01% | -16.7% |
| Q3 2021 | $246,431,000 | -21.1% | 4,921,715 | -0.8% | 0.01% | -25.0% |
| Q2 2021 | $312,370,000 | -31.9% | 4,959,047 | +0.5% | 0.01% | -33.3% |
| Q1 2021 | $458,415,000 | +6.8% | 4,933,970 | +3.0% | 0.01% | 0.0% |
| Q4 2020 | $429,236,000 | -6.0% | 4,790,573 | +8.4% | 0.01% | -20.0% |
| Q3 2020 | $456,601,000 | +21.6% | 4,418,861 | -7.0% | 0.02% | +15.4% |
| Q2 2020 | $375,600,000 | +37.0% | 4,749,596 | +0.2% | 0.01% | +8.3% |
| Q1 2020 | $274,223,000 | +8.9% | 4,739,406 | +1.5% | 0.01% | +33.3% |
| Q4 2019 | $251,798,000 | +3.4% | 4,667,246 | +0.2% | 0.01% | 0.0% |
| Q3 2019 | $243,524,000 | +9.3% | 4,658,076 | +1.0% | 0.01% | +12.5% |
| Q2 2019 | $222,722,000 | -6.3% | 4,610,267 | -2.0% | 0.01% | -11.1% |
| Q1 2019 | $237,664,000 | -17.0% | 4,704,347 | -2.6% | 0.01% | -30.8% |
| Q4 2018 | $286,458,000 | -5.5% | 4,832,301 | +5.0% | 0.01% | +8.3% |
| Q3 2018 | $303,029,000 | +39.1% | 4,603,209 | +6.7% | 0.01% | +33.3% |
| Q2 2018 | $217,862,000 | -0.5% | 4,314,957 | +3.8% | 0.01% | -10.0% |
| Q1 2018 | $218,885,000 | +30.9% | 4,157,350 | +15.6% | 0.01% | +42.9% |
| Q4 2017 | $167,163,000 | +14.7% | 3,597,235 | -0.2% | 0.01% | 0.0% |
| Q3 2017 | $145,751,000 | +21.0% | 3,603,210 | +1.4% | 0.01% | +16.7% |
| Q2 2017 | $120,472,000 | +9.9% | 3,552,692 | -5.8% | 0.01% | 0.0% |
| Q1 2017 | $109,574,000 | -5.6% | 3,773,200 | +6.7% | 0.01% | 0.0% |
| Q4 2016 | $116,090,000 | +0.1% | 3,535,006 | -3.9% | 0.01% | -14.3% |
| Q3 2016 | $115,973,000 | +14.2% | 3,678,168 | +1.9% | 0.01% | +16.7% |
| Q2 2016 | $101,517,000 | -12.6% | 3,610,132 | +13.0% | 0.01% | -25.0% |
| Q1 2016 | $116,127,000 | +0.5% | 3,194,662 | +10.6% | 0.01% | 0.0% |
| Q4 2015 | $115,553,000 | -73.2% | 2,888,089 | -78.4% | 0.01% | -50.0% |
| Q3 2015 | $431,520,000 | +488.6% | 13,382,841 | +501.5% | 0.02% | +220.0% |
| Q2 2015 | $73,312,000 | +18.7% | 2,224,944 | +3.6% | 0.01% | +25.0% |
| Q1 2015 | $61,753,000 | +10.2% | 2,147,185 | +4.4% | 0.00% | 0.0% |
| Q4 2014 | $56,015,000 | +28.7% | 2,057,086 | +0.7% | 0.00% | +33.3% |
| Q3 2014 | $43,512,000 | -3.9% | 2,041,842 | +1.3% | 0.00% | -25.0% |
| Q2 2014 | $45,292,000 | -9.4% | 2,016,586 | +1.9% | 0.00% | 0.0% |
| Q1 2014 | $49,997,000 | +17.9% | 1,978,531 | +7.3% | 0.00% | 0.0% |
| Q4 2013 | $42,393,000 | +27.1% | 1,843,989 | +5.3% | 0.00% | +33.3% |
| Q3 2013 | $33,354,000 | +36.3% | 1,750,811 | +3.2% | 0.00% | 0.0% |
| Q2 2013 | $24,475,000 | – | 1,697,223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |